GO
Loading...

Pharmaceuticals

More

  • Don't panic over Ebola, a survivor says Wednesday, 1 Oct 2014 | 5:25 PM ET
    SIM USA missionary Nancy Writebol discusses her recovery from Ebola, as her husband David looks on, at a news conference at SIM USA headquarters in Charlotte, N.C., Sept. 3, 2014.

    The U.S. has the best medical care in the world, so people shouldn't panic over the first Ebola diagnosis in the country, an Ebola survivor said.

  • NEW YORK, Oct 1- U.S. stocks dropped more than 1 percent on Wednesday as the first diagnosis of Ebola in a patient in the United States spooked investors, economic data pointed to uneven growth, and the Russell 2000 index entered correction territory.

  • BOSTON/ NEW YORK, Oct 1- Prominent investor shareholder advisory firm ISS called on Allergan Inc to give its shareholders a chance to vote on any large, buyout-blocking acquisitions and said the company's board faced a credibility problem, according to a report seen by Reuters.

  • AP Top Extended Financial Headlines At 9 a.m. EDT Wednesday, 1 Oct 2014 | 8:59 AM ET

    General Mills plans to eliminate approximately 700 to 800 jobs, mostly in the US US construction spending expected to show small gain in August Report: Angie's List considers sale of business, talks with possible buyers Shares of drugmakers developing Ebola treatments, vaccines extend gains before markets open RCS Capital to buy subsidiary of American Realty Capital Properties for at least $700 million France's Socialists take axe to welfare spending with planned cuts in 2015 budget

  • AP Top Extended Financial Headlines At 8:52 a.m. EDT Wednesday, 1 Oct 2014 | 8:52 AM ET

    General Mills plans to eliminate approximately 700 to 800 jobs, mostly in the US US construction spending expected to show small gain in August Shares of drugmakers developing Ebola treatments, vaccines extend gains before markets open RCS Capital to buy subsidiary of American Realty Capital Properties for at least $700 million France's Socialists take axe to welfare spending with planned cuts in 2015 budget Germany says Eurofighter jet makers discover manufacturing fault, country suspends deliveries

  • AP Top Extended Financial Headlines At 8:48 a.m. EDT Wednesday, 1 Oct 2014 | 8:48 AM ET

    General Mills plans to eliminate approximately 700 to 800 jobs, mostly in the US US construction spending expected to show small gain in August Shares of drugmakers developing Ebola treatments, vaccines extend gains before markets open RCS Capital to buy subsidiary of American Realty Capital Properties for at least $700 million France's Socialists take axe to welfare spending with planned cuts in 2015 budget Germany says Eurofighter jet makers discover manufacturing fault, country suspends deliveries

  • Ahead of the Bell: Ebola treatment makers rise Wednesday, 1 Oct 2014 | 7:56 AM ET

    Tekmira Pharmaceuticals Corp., Inovio Pharmaceuticals Inc. and NewLink Genetics Corp. all saw their stocks jump 6 percent or more about two hours before the markets open.

  • Stocks start October with a drop Wednesday, 1 Oct 2014 | 3:55 AM ET

    NEW YORK— Financial markets got off to a rough start in October as disappointing economic news and Ebola fears drove stocks lower. The Dow Jones industrial average slumped more than 200 points Wednesday, the first day of trading in a month known for big market swings. "A lot of people thought this economic data was going to be robust, so when it was weak, everyone moved...

  • NEW YORK, Oct. 1- Two tiny companies are preparing to challenge some of the world's largest drug makers in the battle for dominance in the $3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants.

  • UPDATE 1-Retrophin fires founder and CEO Shkreli Tuesday, 30 Sep 2014 | 6:44 PM ET

    Sept 30- Retrophin Inc said it fired founder and Chief Executive Martin Shkreli effective immediately, the second top level change at the drugmaker this month. Retrophin said it had appointed Chief Operating Officer Stephen Aselage as interim CEO. Aselage was the chief business officer at BioMarin Pharmaceutical Inc before joining Retrophin in 2012..

  • CNBC's Meg Tirrell provides insight to comments by the CDC director about the first confirmed Ebola case in the U.S.

  • CDC's Ebola strategy     Tuesday, 30 Sep 2014 | 5:45 PM ET

    CDC Director Dr. Tom Frieden explains the CDC's investment to ensuring the spread of Ebola is stopped.

  • David L. Lakey, M.D., Commissioner of the Texas Department of State Health Services, discusses the handling of the patient with Ebola.

  • CDC Director Dr. Tom Frieden provides insight to the spread of Ebola, and announces an individual traveling from Liberia to the United States has been diagnosed with Ebola in Texas.

  • Awaiting CDC news conference     Tuesday, 30 Sep 2014 | 5:37 PM ET

    CNBC's Melissa Lee reports pharmaceutical companies with potential Ebola treatments are on the move after hours, as well as airline stocks.

  • Sarepta CEO ready with Ebola drug if requested     Tuesday, 30 Sep 2014 | 5:29 PM ET

    Sarepta President and CEO Chris Garabedian says his company has enough clinical trial quality drug on hand to treat a couple dozen Ebola patients if requested.

  • CNBC's Meg Tirrell reports Texas health officials have confirmed the Ebola patient is in Texas, and had a recent history of travel to West Africa.

  • Ebola stocks surge after first US case diagnosed Tuesday, 30 Sep 2014 | 5:04 PM ET
    The Centers for Disease Control sign is seen at its main facility in Atlanta, Georgia.

    Shares of pharmaceutical companies working on a drug to treat Ebola spiked after the CDC confirmed the first case diagnosed in the U.S.

  • Pharma companies spike ahead of CDC newser     Tuesday, 30 Sep 2014 | 5:03 PM ET

    The CDC has confirmed the first Ebola case diagnosed in the U.S. The "Fast Money" traders discuss the companies spiking on the news.

  • First Ebola case confirmed in US     Tuesday, 30 Sep 2014 | 5:00 PM ET

    The CDC has confirmed the first Ebola case diagnosed in the U.S. and will hold a news conference at 5:30PM E.T. Tuesday. CNBC's Meg Tirrell has the details.